Web Desc
Viruses and Human Cancer
Organizer(s): Charles R.M. Bangham, Thomas F. Schulz and Paul M. Lieberman
Date: March 29 - April 03, 2015
Location: Big Sky Resort, Big Sky, MT, USA
Sponsored by Merck & Co., Inc., Regeneron Pharmaceuticals, Inc. and Roche
Summary of Meeting:
In 1970, an authoritative book entitled “Viruses and Cancer” was published by Sir Christopher Andrews, one of the discoverers of influenza virus. On page 135 he wrote “Despite these findings, there is no doubt that as regards the generality of cancers in man, and indeed in other mammals, there is no direct evidence that viruses are concerned”. It is now estimated that about 20% of human cancers are caused by infectious agents, among them at least 7 viruses. The increasing appreciation of the role of viruses in cancer pathogenesis has not only already led to the development of two successful vaccines (against HBV and HPV) that prevent cancer, it has also directly contributed to many fundamental discoveries in cancer biology. In the last decade the understanding of virus-induced cancers has been accelerated by the extraordinary developments in genomics, epigenetics and RNA biology. To review this rapidly burgeoning field, this multidisciplinary symposium brings together experts in virology, oncology, immunology, genomics and genetics. The objective of the symposium is to explore how advances in cancer biology can inform the understanding of virus-induced cancers, and how viruses continue to reveal fundamental principles in cancer. Particular emphasis will be laid on the interaction between virus and host in persistent infections by oncogenic viruses. The meeting will cover examples of cancers where a viral cause is still under debate and the rapid development of technology for the detection of unknown viruses.
Scholarship Deadline: December 2 2014
Discounted Abstract Deadline: December 2 2014
Abstract Deadline: January 6 2015
Discounted Registration Deadline: January 27 2015
Keystone Symposia thanks our Sponsor(s) for generously supporting this meeting:
Merck & Co., Inc.Regeneron Pharmaceuticals, Inc.Roche
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:

Novartis Institutes for BioMedical Research
We gratefully acknowledge the generous grant for this conference provided by:

National Cancer Institute (NCI)
Grant No. 1R13CA192463-01
Funding for this conference was made possible (in part) by 1R13CA192463-01 from the National Cancer Institute. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations
Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations

Program

Sunday, March 29 | 4:00PM - 8:00PM
Arrival and Registration
Room: Lower Atrium


Sunday, March 29 | 6:00PM - 8:00PM
Welcome Mixer
Room: Jefferson
No registration fees are used to fund alcohol served at this function.

Monday, March 30 | 7:00AM - 8:00AM
Breakfast
Room: Gallatin


Monday, March 30 | 8:00AM - 8:15AM
Welcome Remarks
Room: Jefferson/Madison

Speaker 1 of 1
Charles R.M. Bangham, Imperial College Department of Medicine, UK

Monday, March 30 | 8:00AM - 11:30AM
Mimicry of Host Pathways
Room: Jefferson/Madison

Speaker 1 of 6
* Thomas F. Schulz, Medizinische Hochschule Hannover, Germany

Monday, March 30 | 8:00AM - 11:30AM
Mimicry of Host Pathways
Room: Jefferson/Madison

Speaker 2 of 6
Carolina Arias, University of California, Santa Barbara, USA
Cell Lineage Dramatically Impacts Kaposi’s Sarcoma-Associated Herpesvirus Gene Expression

Monday, March 30 | 8:00AM - 11:30AM
Mimicry of Host Pathways
Room: Jefferson/Madison

Speaker 3 of 6
Blossom A. Damania, University of North Carolina at Chapel Hill, USA
Subversion of Host Cell Signaling by KSHV

Monday, March 30 | 8:00AM - 11:30AM
Mimicry of Host Pathways
Room: Jefferson/Madison

Speaker 4 of 6
Ulrike Protzer, Technische Universität München, Germany
Cytolytic and Non-Cytolytic Control of Hepatitis B Virus Persistence

Monday, March 30 | 8:00AM - 11:30AM
Mimicry of Host Pathways
Room: Jefferson/Madison

Speaker 5 of 6
Eleonora Forte, Northwestern University, USA
Short Talk: A Partial Tumor Virus Mimic of miR-142-3p Disrupts Adherens Junctions

Monday, March 30 | 8:00AM - 11:30AM
Mimicry of Host Pathways
Room: Jefferson/Madison

Speaker 6 of 6
Lori D. Frappier, University of Toronto, Canada
Short Talk: Mechanism and Consequences of CK2 Kinase Hijacking by Epstein-Barr Virus Nuclear Antigen 1 (EBNA1)

Monday, March 30 | 9:20AM - 9:40AM
Coffee Break
Room: Lower Atrium


Monday, March 30 | 11:30AM - 1:00PM
Poster Setup
Room: Gallatin


Monday, March 30 | 11:30AM - 2:30PM
On Own for Lunch


Monday, March 30 | 1:00PM - 10:00PM
Poster Viewing
Room: Gallatin


Monday, March 30 | 2:30PM - 4:30PM
Workshop 1: Viral Mimicry
Room: Jefferson/Madison

Speaker 1 of 7
* Paul M. Lieberman, Wistar Institute, USA

Monday, March 30 | 2:30PM - 4:30PM
Workshop 1: Viral Mimicry
Room: Jefferson/Madison

Speaker 2 of 7
Silvia Gramolelli, Hannover Medical School, Germany
Kaposi Sarcoma Herpesvirus (KSHV) K15 Protein Contributes to the Increased Invasiveness and Angiogenic Properties of Infected Endothelial Cells

Monday, March 30 | 2:30PM - 4:30PM
Workshop 1: Viral Mimicry
Room: Jefferson/Madison

Speaker 3 of 7
Alexander S. Hahn, University of Erlangen-Nuremberg, Germany
Rhadinovirus Receptor Tropism for Endothelial Cell Surface Molecules

Monday, March 30 | 2:30PM - 4:30PM
Workshop 1: Viral Mimicry
Room: Jefferson/Madison

Speaker 4 of 7
Christine Happel, NCI, National Institutes of Health, USA
KSHV Regulation of the MicroRNA Biogenesis Pathway

Monday, March 30 | 2:30PM - 4:30PM
Workshop 1: Viral Mimicry
Room: Jefferson/Madison

Speaker 5 of 7
Robert F. Kalejta, University of Wisconsin-Madison, USA
Retinoblastoma Protein Cleft and LxCxE Docking Motif Required for Human Cytomegalovirus vCdk UL97-Mediated Activation of E2F-Responsive Transcription

Monday, March 30 | 2:30PM - 4:30PM
Workshop 1: Viral Mimicry
Room: Jefferson/Madison

Speaker 6 of 7
Frank Neipel, Universitaet Erlangen, Germany
The Ephrin A2 Receptor Tyrosin Kinase (EphA2) Is Required for KSHV Endocytosis and Membrane Fusion in Endothelial Cells

Monday, March 30 | 2:30PM - 4:30PM
Workshop 1: Viral Mimicry
Room: Jefferson/Madison

Speaker 7 of 7
Vijay Kumar, International Centre for Genetic Engineering and Biotechnology, India
HBx Oncoprotein Hijacks the Nucleolar Functions to Promote Cellular Transformation

Monday, March 30 | 4:30PM - 5:00PM
Coffee Available
Room: Lower Atrium


Monday, March 30 | 5:00PM - 7:15PM
Latency and Persistence I
Room: Jefferson/Madison

Speaker 1 of 6
* Maria G. Masucci, Karolinska Institute, Sweden

Monday, March 30 | 5:00PM - 7:15PM
Latency and Persistence I
Room: Jefferson/Madison

Speaker 2 of 6
Alison A. McBride, NIAID, National Institutes of Health, USA
Papillomaviruses exploit Multiple Cellular Processes to Replicate their Genomes at Different Phases of the Virus Life Cycle

Monday, March 30 | 5:00PM - 7:15PM
Latency and Persistence I
Room: Jefferson/Madison

Speaker 3 of 6
David Thorley-Lawson, Tufts University School of Medicine, USA
How EBV Persists in vivo and its Relevance to Human Cancer

Monday, March 30 | 5:00PM - 7:15PM
Latency and Persistence I
Room: Jefferson/Madison

Speaker 4 of 6
Paul M. Lieberman, Wistar Institute, USA
Epigenetic Regulation of Gammaherpesvirus Latency

Monday, March 30 | 5:00PM - 7:15PM
Latency and Persistence I
Room: Jefferson/Madison

Speaker 5 of 6
Giuseppe Balistreri, University of Helsinki, Finland
Short Talk: Stress Response and G2 Cell-Cycle Arrest during KSHV Lytic Phase Ensure Efficient Viral Lytic Gene Expression and Make Reactivated Cells Addicted to Anti-Apoptotic Pathways

Monday, March 30 | 5:00PM - 7:15PM
Latency and Persistence I
Room: Jefferson/Madison

Speaker 6 of 6
Jennifer Corcoran, Dalhousie University, Canada
Short Talk: Viral Activation of MK2-hsp27-p115RhoGEF-RhoA Signaling Axis Causes Cytoskeletal Rearrangements, P-Body Disruption and ARE-mRNA Stabilization

Monday, March 30 | 7:15PM - 8:15PM
Social Hour with Lite Bites
Room: Gallatin
No registration fees are used to fund alcohol served at this function.

Monday, March 30 | 7:30PM - 10:00PM
Poster Session 1
Room: Gallatin


Tuesday, March 31 | 7:00AM - 8:00AM
Breakfast
Room: Gallatin


Tuesday, March 31 | 8:00AM - 11:00AM
Inflammation and Tumor Microenvironment
Room: Jefferson/Madison

Speaker 1 of 7
* Ulrike Protzer, Technische Universität München, Germany

Tuesday, March 31 | 8:00AM - 11:00AM
Inflammation and Tumor Microenvironment
Room: Jefferson/Madison

Speaker 2 of 7
Stacy M. Horner, Duke University Medical Center, USA
Activation and Evasion of Innate Immune and Inflammatory Signaling by HCV

Tuesday, March 31 | 8:00AM - 11:00AM
Inflammation and Tumor Microenvironment
Room: Jefferson/Madison

Speaker 3 of 7
Paivi M. Ojala, Institute of Biotechnology, University of Helsinki, Finland
Lymphatic Reprogramming in KSHV Pathogenesis and Cancer



Tuesday, March 31 | 8:00AM - 11:00AM
Inflammation and Tumor Microenvironment
Room: Jefferson/Madison

Speaker 4 of 7
Benjamin E. Gewurz, Brigham and Women's Hospital, Harvard Medical School, USA
Short Talk: The NF-kappaB Landscape in EBV-Transformed Lymphoblastoid B-Cells

Tuesday, March 31 | 8:00AM - 11:00AM
Inflammation and Tumor Microenvironment
Room: Jefferson/Madison

Speaker 5 of 7
Mei-Ru Chen, National Taiwan University, Taiwan
Modification of Nuclear Envelope Induced by EBV Replication

Tuesday, March 31 | 8:00AM - 11:00AM
Inflammation and Tumor Microenvironment
Room: Jefferson/Madison

Speaker 6 of 7
Sang Hyuk Chung, University of Houston, USA
Short Talk: Mechanisms by which Estrogen Receptor alpha Cooperates with HPV Oncogenes for Cervical Carcinogenesis

Tuesday, March 31 | 8:00AM - 11:00AM
Inflammation and Tumor Microenvironment
Room: Jefferson/Madison

Speaker 7 of 7
Masaru Shimada, Yokohama City University, Japan
Short Talk: The Role of Apoptosis Inducing Factor 1 (AIFM1) in HPV-Inducing Cancer

Tuesday, March 31 | 9:20AM - 9:40AM
Coffee Break
Room: Lower Atrium


Tuesday, March 31 | 11:00AM - 1:00PM
Poster Setup
Room: Gallatin


Tuesday, March 31 | 11:00AM - 5:00PM
On Own for Lunch


Tuesday, March 31 | 1:00PM - 10:00PM
Poster Viewing
Room: Gallatin


Tuesday, March 31 | 4:30PM - 5:00PM
Coffee Available
Room: Lower Atrium


Tuesday, March 31 | 5:00PM - 7:30PM
Latency and Persistence II
Room: Jefferson/Madison

Speaker 1 of 6
* Paul M. Lieberman, Wistar Institute, USA

Tuesday, March 31 | 5:00PM - 7:30PM
Latency and Persistence II
Room: Jefferson/Madison

Speaker 2 of 6
Masao Matsuoka, Kyoto University, Japan
Role of HTLV-1 bZIP Factor Gene in Viral Pathogenesis

Tuesday, March 31 | 5:00PM - 7:30PM
Latency and Persistence II
Room: Jefferson/Madison

Speaker 3 of 6
Charles R.M. Bangham, Imperial College Department of Medicine, UK
Regulation of HTLV-1 Clonality: When Does Leukemia Result?

Tuesday, March 31 | 5:00PM - 7:30PM
Latency and Persistence II
Room: Jefferson/Madison

Speaker 4 of 6
Maria G. Masucci, Karolinska Institute, Sweden
Disruption of Cellular Processes in Epstein-Barr Virus Replication and Oncogenesis

Tuesday, March 31 | 5:00PM - 7:30PM
Latency and Persistence II
Room: Jefferson/Madison

Speaker 5 of 6
Thomas F. Schulz, Medizinische Hochschule Hannover, Germany
BET Chromatin Proteins Regulate Gammaherpesviral Latency and Retroviral Integration

Tuesday, March 31 | 5:00PM - 7:30PM
Latency and Persistence II
Room: Jefferson/Madison

Speaker 6 of 6
Vaibhav Jain, University of Florida, USA
Short Talk: Role of LANA N-Terminus Histone Binding Domain in Transcriptional Control and Episome Maintenance

Tuesday, March 31 | 7:30PM - 8:30PM
Social Hour with Lite Bites
Room: Gallatin
No registration fees are used to fund alcohol served at this function.

Tuesday, March 31 | 7:30PM - 10:00PM
Poster Session 2
Room: Gallatin


Wednesday, April 01 | 7:00AM - 8:00AM
Breakfast
Room: Gallatin


Wednesday, April 01 | 8:00AM - 11:15AM
Genetics and Epigenetics I
Room: Jefferson/Madison

Speaker 1 of 7
* Martin J. Allday, Imperial College London, UK

Wednesday, April 01 | 8:00AM - 11:15AM
Genetics and Epigenetics I
Room: Jefferson/Madison

Speaker 2 of 7
Yorifumi Satou, Kumamoto University, Japan
HTLV-1 Inserts an Ectopic CTCF-Binding Site into the Human Genome

Wednesday, April 01 | 8:00AM - 11:15AM
Genetics and Epigenetics I
Room: Jefferson/Madison

Speaker 3 of 7
Lucas L. Willems, Université de Liège, FNRS, Belgium
Mechanisms of BLV Persistence and Leukemogenesis

Wednesday, April 01 | 8:00AM - 11:15AM
Genetics and Epigenetics I
Room: Jefferson/Madison

Speaker 4 of 7
Paul F. Lambert, University of Wisconsin, USA
What Drives Development of HPV-Associated Cancers?

Wednesday, April 01 | 8:00AM - 11:15AM
Genetics and Epigenetics I
Room: Jefferson/Madison

Speaker 5 of 7
Christine E. Birdwell, Louisiana State University Health Sciences Center-Shreveport, USA
Short Talk: Epigenetic Consequences of Epstein-Barr Infection in Epithelial Cells

Wednesday, April 01 | 8:00AM - 11:15AM
Genetics and Epigenetics I
Room: Jefferson/Madison

Speaker 6 of 7
Sarah Jill de Jong, Rockefeller University, USA
Short Talk: EV3 Deficiency - A New Genetic Etiology Predisposing to Severe beta-HPV Infection and Squamous Cell Carcinoma

Wednesday, April 01 | 8:00AM - 11:15AM
Genetics and Epigenetics I
Room: Jefferson/Madison

Speaker 7 of 7
Massimo Tommasino, Infections and Cancer Biology Group-IARC, France
Role of Viral Infections in Human Cancers

Wednesday, April 01 | 9:20AM - 9:40AM
Coffee Break
Room: Lower Atrium


Wednesday, April 01 | 11:15AM - 2:30PM
On Own for Lunch


Wednesday, April 01 | 2:30PM - 4:30PM
Workshop 2: Innate Defense
Room: Jefferson/Madison

Speaker 1 of 7
* Lucas L. Willems, Université de Liège, FNRS, Belgium

Wednesday, April 01 | 2:30PM - 4:30PM
Workshop 2: Innate Defense
Room: Jefferson/Madison

Speaker 2 of 7
Amy Y. Hafez, Duke University, USA
EBV-Mediated B-Cell Transformation Is Suppressed by Oncogene-Induced Senescence through the DNA Damage Response

Wednesday, April 01 | 2:30PM - 4:30PM
Workshop 2: Innate Defense
Room: Jefferson/Madison

Speaker 3 of 7
Alexander M. Price, Duke University, USA
Characterizing Survival in the Absence of LMP1-Mediated NF-kappaB Signaling Early after B-Cell Infection

Wednesday, April 01 | 2:30PM - 4:30PM
Workshop 2: Innate Defense
Room: Jefferson/Madison

Speaker 4 of 7
Erica L. Sanchez, San Francisco State University, USA
Latent KSHV Infected Endothelial Cells Are Glutamine Addicted and Require Glutaminolysis for Survival

Wednesday, April 01 | 2:30PM - 4:30PM
Workshop 2: Innate Defense
Room: Jefferson/Madison

Speaker 5 of 7
Guigen Zhang, Hannover Medical School, Germany
Recruitment of an Innate Immune DNA Sensor by the Cytoplasmic Isoforms of KSHV LANA

Wednesday, April 01 | 2:30PM - 4:30PM
Workshop 2: Innate Defense
Room: Jefferson/Madison

Speaker 6 of 7
Joseph M. Ziegelbauer, NCI, National Institutes of Health, USA
KSHV MicroRNAs Target Growth Arrest and DNA Damage-Inducible Gene (GADD45B) and Protect Cells from DNA Damage Consequences

Wednesday, April 01 | 2:30PM - 4:30PM
Workshop 2: Innate Defense
Room: Jefferson/Madison

Speaker 7 of 7
Martin K. Thomsen, Aarhus University, Denmark
The Innate DNA Sensing Pathway Is Not Operative in Hepatocytes: Impact on HBV Infection

Wednesday, April 01 | 2:30PM - 4:30PM
Workshop 3: Virus Discovery and Therapy
Room: Amphitheater

Speaker 1 of 7
* W. Ian Lipkin, Columbia University, USA

Wednesday, April 01 | 2:30PM - 4:30PM
Workshop 3: Virus Discovery and Therapy
Room: Amphitheater

Speaker 2 of 7
Alan K. Chiang, University of Hong Kong, Hong Kong
Targeting EBV in EBV-Associated Malignancies

Wednesday, April 01 | 2:30PM - 4:30PM
Workshop 3: Virus Discovery and Therapy
Room: Amphitheater

Speaker 3 of 7
Johanna Classon, Karolinska Institutet, Sweden
Human Cytomegalovirus and the Androgen Receptor in Prostate Cancer

Wednesday, April 01 | 2:30PM - 4:30PM
Workshop 3: Virus Discovery and Therapy
Room: Amphitheater

Speaker 4 of 7
David Stein, Oregon State University, USA
Inhibition of Primary Effusion Lymphoma in SCID Mice by Blocking the Expression of vIL-6 in an Oncogenic Virus

Wednesday, April 01 | 2:30PM - 4:30PM
Workshop 3: Virus Discovery and Therapy
Room: Amphitheater

Speaker 5 of 7
Ruth F. Jarrett, University of Glasgow, UK
Viruses and Hodgkin Lymphoma

Wednesday, April 01 | 2:30PM - 4:30PM
Workshop 3: Virus Discovery and Therapy
Room: Amphitheater

Speaker 6 of 7
Jaap M. Middeldorp, VU University Medical Center, Netherlands
Cytolytic Virus Activation Therapy for Epstein-Barr Virus Driven Tumors

Wednesday, April 01 | 2:30PM - 4:30PM
Workshop 3: Virus Discovery and Therapy
Room: Amphitheater

Speaker 7 of 7
J.J. Miranda, Gladstone Institutes and University of California, San Francisco, USA
Viral Specificity of Small Molecule Latency Disruptors

Wednesday, April 01 | 4:30PM - 5:00PM
Coffee Available
Room: Lower Atrium


Wednesday, April 01 | 5:00PM - 6:40PM
Genetics and Epigenetics II
Room: Jefferson/Madison

Speaker 1 of 5
* Paul F. Lambert, University of Wisconsin, USA

Wednesday, April 01 | 5:00PM - 6:40PM
Genetics and Epigenetics II
Room: Jefferson/Madison

Speaker 2 of 5
Martin J. Allday, Imperial College London, UK
EBNA3 Proteins and the Modulation of Nuclear Processes during the Transformation of B Cells by EBV

Wednesday, April 01 | 5:00PM - 6:40PM
Genetics and Epigenetics II
Room: Jefferson/Madison

Speaker 3 of 5
Matthew D. Weitzman, Children's Hospital of Philadelphia, USA
Viral Manipulation of DNA Replication and Damage Responses

Wednesday, April 01 | 5:00PM - 6:40PM
Genetics and Epigenetics II
Room: Jefferson/Madison

Speaker 4 of 5
Micah A. Luftig, Duke University Medical Center, USA
Short Talk: A New Temporal Model for Epstein-Barr Virus Immortalization of Human B Cells

Wednesday, April 01 | 5:00PM - 6:40PM
Genetics and Epigenetics II
Room: Jefferson/Madison

Speaker 5 of 5
Kayla Martin, Temple University, USA
Short Talk: Epstein-Barr Virus Protein LMP1 Mediates Epigenetic-Driven Changes in Host and Viral Gene Expression through PARP1

Wednesday, April 01 | 6:40PM - 7:15PM
Immunity, Intracellular Defense and Vaccines
Room: Jefferson/Madison

Speaker 1 of 1
John T. Schiller, NCI, National Institutes of Health, USA
Prophylactic HPV Vaccines: Why They Work So Well

Wednesday, April 01 | 7:15PM - 8:15PM
Social Hour with Lite Bites
Room: Gallatin
No registration fees are used to fund alcohol served at this function.

Thursday, April 02 | 7:00AM - 8:00AM
Breakfast
Room: Gallatin


Thursday, April 02 | 8:00AM - 11:15AM
Host Defense
Room: Jefferson/Madison

Speaker 1 of 7
* Charles R.M. Bangham, Imperial College Department of Medicine, UK

Thursday, April 02 | 8:00AM - 11:15AM
Host Defense
Room: Jefferson/Madison

Speaker 2 of 7
Barbara Rehermann, NIDDK, National Institutes of Health, USA
Host Responses to HCV: Inflammation and Innate Immune Cell Responses

Thursday, April 02 | 8:00AM - 11:15AM
Host Defense
Room: Jefferson/Madison

Speaker 3 of 7
Adam J. Gehring, St. Louis University School of Medicine, USA
Immunotherapy for Chronic HBV Infection and HBV-Related Liver Cancer: New Strategies to Exploit the Viral Life Cycle for Personalize Therapy

Thursday, April 02 | 8:00AM - 11:15AM
Host Defense
Room: Jefferson/Madison

Speaker 4 of 7
Genoveffa Franchini, NCI, National Institutes of Health, USA
Polymorphisms in the Orf-I Gene in HTLV-I Replication in Monocytes and Immune Evasion

Thursday, April 02 | 8:00AM - 11:15AM
Host Defense
Room: Jefferson/Madison

Speaker 5 of 7
Cliona M. Rooney, Baylor College of Medicine, USA
Use of Viruses to Enhance the Efficacy of CAR-T-Cells

Thursday, April 02 | 8:00AM - 11:15AM
Host Defense
Room: Jefferson/Madison

Speaker 6 of 7
Cécile Bauche, Theravectys, France
Short Talk: Development of an Anti-HTLV-1 Vaccine for the Treatment of Adult T-Cell Leukemia/Lymphoma

Thursday, April 02 | 8:00AM - 11:15AM
Host Defense
Room: Jefferson/Madison

Speaker 7 of 7
Katja Spiess, University of Copenhagen, Denmark
Short Talk: A Rationally Designed Chemokine-Based Toxin Targeting Human Cytomegalovirus Provides Efficient and Selective Killing of HCMV Infected Cells

Thursday, April 02 | 9:20AM - 9:40AM
Coffee Break
Room: Lower Atrium


Thursday, April 02 | 11:15AM - 5:00PM
On Own for Lunch


Thursday, April 02 | 4:30PM - 5:00PM
Coffee Available
Room: Lower Atrium


Thursday, April 02 | 5:00PM - 7:00PM
Genomics and Virus Discovery
Room: Jefferson/Madison

Speaker 1 of 5
* Ruth F. Jarrett, University of Glasgow, UK

Thursday, April 02 | 5:00PM - 7:00PM
Genomics and Virus Discovery
Room: Jefferson/Madison

Speaker 2 of 5
Patrick S. Moore, University of Pittsburgh Cancer Institute, USA
How to Find a New Human Virus: Lessons from Merkel Cell Polyomavirus and Kaposi's Sarcoma Herpesvirus

Thursday, April 02 | 5:00PM - 7:00PM
Genomics and Virus Discovery
Room: Jefferson/Madison

Speaker 3 of 5
Anne Palser, Wellcome Trust Sanger Institute, UK
EBV Sequencing Data

Thursday, April 02 | 5:00PM - 7:00PM
Genomics and Virus Discovery
Room: Jefferson/Madison

Speaker 4 of 5
W. Ian Lipkin, Columbia University, USA
Microbe Hunting

Thursday, April 02 | 5:00PM - 7:00PM
Genomics and Virus Discovery
Room: Jefferson/Madison

Speaker 5 of 5
Aaron J. Arvey, Gilead, USA
Short Talk: Host and Viral Transcriptome Landscape of AIDS-Related Lymphomas

Thursday, April 02 | 7:00PM - 7:15PM
Meeting Wrap-Up: Outcomes and Future Directions (Organizers)
Room: Jefferson/Madison


Thursday, April 02 | 7:15PM - 8:15PM
Social Hour with Lite Bites
Room: Gallatin
No registration fees are used to fund alcohol served at this function.

Thursday, April 02 | 8:00PM - 11:00PM
Entertainment
Room: Gallatin
Entertainment is not subsidized by conference registration fees nor any U.S. federal government grants. Funding for this expense is provided by other revenue sources.

Thursday, April 02 | 8:00PM - 11:00PM
Cash Bar
Room: Gallatin


Friday, April 03 | 10:25AM - 10:25AM
Departure


*Session Chair.